Capital Impact Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,425
| Closed | -$657K | – | 3 |
|
|
2024
Q2 | $657K | Hold |
16,425
| – | – | 1.85% | 27 |
|
|
2024
Q1 | $721K | Buy |
16,425
+1,121
| +7% | +$49.2K | 0.94% | 43 |
|
|
2023
Q4 | $947K | Hold |
15,304
| – | – | 1.24% | 30 |
|
|
2023
Q3 | $704K | Hold |
15,304
| – | – | 1.18% | 34 |
|
|
2023
Q2 | $880K | Hold |
15,304
| – | – | 0.97% | 18 |
|
|
2023
Q1 | $574K | Buy |
15,304
+635
| +4% | +$23.8K | 0.7% | 55 |
|
|
2022
Q4 | $411K | Hold |
14,669
| – | – | 0.4% | 106 |
|
|
2022
Q3 | $416K | Buy |
14,669
+834
| +6% | +$23.7K | 0.41% | 99 |
|
|
2022
Q2 | $481K | Sell |
13,835
-3,925
| -22% | -$136K | 0.44% | 100 |
|
|
2022
Q1 | $638K | Buy |
+17,760
| New | +$638K | 0.46% | 107 |
|